2021
Optimal Timing of SBRT for Treatment of Oligometastatic Disease: A Single Institution Retrospective Analysis
Gao S, Yu J, Park H, Decker R. Optimal Timing of SBRT for Treatment of Oligometastatic Disease: A Single Institution Retrospective Analysis. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e476-e477. DOI: 10.1016/j.ijrobp.2021.07.1324.Peer-Reviewed Original ResearchCurative-intent stereotactic body radiation therapyStereotactic body radiation therapyUpfront systemic therapyKarnofsky performance scoreProgression-free survivalSystemic therapyOverall survivalOligometastatic diseaseSequential therapyWorse survivalOligometastatic settingConcurrent therapyImproved survivalHigher Karnofsky performance scoreSingle-institution retrospective analysisOptimal timingCox proportional hazards modelExtracranial metastatic lesionsImproved overall survivalPrimary tumor locationMajority of patientsConcurrent systemic therapyMultivariate Cox analysisBody radiation therapyProportional hazards model
2017
RTHP-16. PATTERNS OF TREATMENT AND OUTCOMES OF 1p19q CO-DELETED GLIOMAS
Yeboa D, Yu J, Huse J, Penas-Prado M, Sulman E, Contessa J. RTHP-16. PATTERNS OF TREATMENT AND OUTCOMES OF 1p19q CO-DELETED GLIOMAS. Neuro-Oncology 2017, 19: vi222-vi222. PMCID: PMC5692027, DOI: 10.1093/neuonc/nox168.900.Peer-Reviewed Original ResearchGrade III tumorsCombined-modality therapyRadiation therapyCox multivariable proportional hazards modelMultivariable proportional hazards modelsNational Cancer DatabasePatterns of treatmentGrade II tumorsPatterns of carePost-operative therapyProportional hazards modelLow-grade gliomasOverall survivalII tumorsHistologic gradeCancer DatabaseTumor gradeGrade IITreatment outcomesAdditional molecular characterizationHazards modelGrade gliomasPatientsTherapyGliomas